Home > Insider Trading > Filing (0001225208-25-003073)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
78003	Pfizer Inc	PFE	Pharmaceutical Preparations (2834)	135315170

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1805617	B. Jennifer Damico	66 Hudson Boulevard East Attn: Corporate Secretary New York NY 10001-2192	Svp & Controller	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2025-02-27	749	$26.10	29,761	No	4	F	Direct
Common Stock	Acquisiton	2025-03-04	5,583	$0.00	14,350	No	4	A	Direct
Common Stock	Disposition	2025-03-04	2,500	$25.93	11,850	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	A	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Appreciation Rights	Acquisiton	2025-03-04	47,511	$0.00	47,511	$25.75

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
47,511	2030-03-04	2030-03-04	No	4	A	Direct

Footnotes

The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).
The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.
The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.